Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01732315 · ClinicalTrials.gov registry record · NA

Adolescent Vaccination Reminder Study

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
3,783
Enrollment target

NCT01732315: Completed NA study, sponsored by University of Colorado, Denver.

NCT01732315 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 3,783 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (169% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01732315, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
3,783 participants
Enrollment target

Study Summary

This protocol describes a study about vaccination uptake among adolescents. The purpose of the study is to determine whether parents who receive email reminders will be more likely to obtain Tdap (tetanus-diphtheria-acellular pertussis), HPV (human papilloma virus), meningococcal, and influenza vaccines for their adolescent children than parents who do not receive email reminders.

Primary Outcome

To examine the effect of email vaccination reminders, new immunization doses of children of parents who receive email vaccination reminders, versus those who do not receive email reminders during the study period will be determined. New doses are those for any of four adolescent vaccines which are administered following the reminder notification, and are subsequently recorded following reminder notifications.

Interventions

  • BEHAVIORAL Email Notification

Trial Details

FieldValue
Enrollment Target 3,783 participants
Start Date 2012-10
Est. Completion 2014-12
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT01732315 record still lists

NCT01732315 is an interventional study that assigns participants to a tested intervention. Its 3,783 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (169% higher).

The record links to 0 conditions, and to 1 intervention - of which Email Notification is the first listed.

NCT01732315 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01732315 about?

NCT01732315 is a clinical study titled "Adolescent Vaccination Reminder Study". This protocol describes a study about vaccination uptake among adolescents. The purpose of the study is to determine whether parents who receive email reminders will be more likely to obtain Tdap (tetanus-diphtheria-acellular pertussis), HPV (human papilloma virus), meningococcal, and influenza vacc...

What is the current status of trial NCT01732315?

This trial is currently completed. It is a NA study. The enrollment target is 3,783 participants. The study started on 2012-10. Estimated completion is 2014-12.

What interventions are being tested in trial NCT01732315?

The interventions under investigation include: Email Notification (BEHAVIORAL).

Who is sponsoring clinical trial NCT01732315?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01732315's enrollment target sits among peer trials

3,783 36th of 2000 higher than 1,965 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04573660 · 3,784 participants

    Abbott Vascular Medical Device Registry

  • NCT06172660 · 3,750 participants

    Real-World Effectiveness of Perinatal RSV Immunoprophylaxis

  • NCT06298253 · 3,750 participants · NA

    Behavioral Economics to Implement a Traffic Light Nutrition Ranking System: Study 2

  • NCT06076304 · 3,720 participants · Phase 4

    Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01732315, the US trial registry maintained by the National Library of Medicine. NCT01732315 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.